Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 681976, 10 pages
http://dx.doi.org/10.1155/2015/681976
Research Article

Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests

1Department of Neurological and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134 Verona, Italy
2Department of General Psychology, University of Padova, Via Venezia 8, 35100 Padua, Italy
3Human Inspired Technologies Research Center, University of Padova, Via Venezia 8, 35100 Padua, Italy
4Neurology Unit Pederzoli Hospital, Via Monte Baldo 24, 37019 Peschiera del Garda, Italy
5Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Piazzale Scuro 10, 37134 Verona, Italy

Received 8 June 2015; Revised 17 September 2015; Accepted 17 September 2015

Academic Editor: Hélio Teive

Copyright © 2015 Angela Federico et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Elham Jaberi, Mohammad Rohani, Gholam Ali Shahidi, Shahriar Nafissi, Ehsan Arefian, Masoud Soleimani, Abolfazl Moghadam, Mohsen Karimi Arzenani, Farid Keramatian, Brandy Klotzle, Jian-Bing Fan, Casey Turk, Frank Steemers, and Elahe Elahi, “ Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction ,” Movement Disorders, 2016. View at Publisher · View at Google Scholar
  • Francesca Magrinelli, Alessandro Picelli, Pierluigi Tocco, Angela Federico, Laura Roncari, Nicola Smania, Giampietro Zanette, and Stefano Tamburin, “Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation,” Parkinson's Disease, vol. 2016, pp. 1–18, 2016. View at Publisher · View at Google Scholar
  • Michela Trentin, Alessandro Picelli, Angela Federico, Giampietro Zanette, Daniela Mapelli, Nicola Smania, Michele Tinazzi, and Stefano Tamburin, “Diagnosing mild cognitive impairment in Parkinson’s disease: which tests perform best in the Italian population?,” Neurological Sciences, vol. 38, no. 8, pp. 1461–1468, 2017. View at Publisher · View at Google Scholar
  • Matej Skorvanek, Jennifer G. Goldman, Marjan Jahanshahi, Connie Marras, Irena Rektorova, Ben Schmand, Erik van Duijn, Christopher G. Goetz, Daniel Weintraub, Glenn T. Stebbins, and Pablo Martinez-Martin, “Global scales for cognitive screening in Parkinson's disease: Critique and recommendations,” Movement Disorders, 2017. View at Publisher · View at Google Scholar
  • Md Shadab, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyar Shahzad, Mujtaba Ali, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota, and Javed Ali, “Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders,” Journal of Drug Delivery Science and Technology, 2017. View at Publisher · View at Google Scholar
  • Michele Tinazzi, Stefano Tamburin, and Angela Federico, “MoCA for cognitive screening in Parkinson's disease: Beware of floor effect,” Movement Disorders, vol. 33, no. 3, pp. 499, 2018. View at Publisher · View at Google Scholar
  • Pablo Martinez-Martin, Christopher G. Goetz, Matej Skorvanek, Marjan Jahanshahi, Irena Rektorova, Daniel Weintraub, Glenn T. Stebbins, Jennifer G. Goldman, Connie Marras, Ben Schmand, and Erik van Duijn, “Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect,” Movement Disorders, vol. 33, no. 3, pp. 499–500, 2018. View at Publisher · View at Google Scholar